Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study

  1. Griesinger, F.
  2. Curigliano, G.
  3. Subbiah, V.
  4. Baik, C.S.
  5. Tan, D.S.
  6. Lee, D.H.
  7. Misch, D.
  8. Garralda, E.
  9. Kim, D.-W.
  10. van der Wekken, A.J.
  11. Gainor, J.F.
  12. Paz-Ares, L.
  13. Liu, S.V.
  14. Kalemkerian, G.P.
  15. Bowles, D.W.
  16. Mansfield, A.S.
  17. Lin, J.J.
  18. Smoljanovic, V.
  19. Rahman, A.
  20. Zalutskaya, A.
  21. Louie-Gao, M.
  22. Boral, A.L.
  23. Mazières, J.
Revue:
Future oncology (London, England)

ISSN: 1744-8301

Année de publication: 2024

Volumen: 20

Número: 6

Pages: 297-306

Type: Révision

DOI: 10.2217/FON-2023-0155 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus